According to the report, the soft tissue market size was valued at US$ 4.4 billion in 2021 and is expected to reach US$ 8.5 billion by 2030, expanding growth at a noteworthy CAGR of 7.1% from 2021 to 2030.
Soft Tissue Market (By Product Type: Cartilage Allografts, Tendon Allografts, Meniscus, Ligament Allografts, Artificial Cornea, Dental Allografts, Collagen Allografts, Amniotic Allografts; By End User: Hospitals, Orthopedic Clinics, and Others) – Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030
Get Sample Copy of This Report (Including TOC, List of Tables & Figures, and Chart)@ https://www.visionresearchreports.com/report/sample/38745
Soft tissue refers to muscle, fat, fibrous tissue, blood vessels, or other supporting tissue of the body. Soft tissue allograft is used in ACL repair, joint reconstruction in the knee & ankle, meniscal replacement, reconstruction due to cancer or trauma, ridge augmentation in dental procedures, shoulder repair, spinal fusion, and urological procedures. Different types of soft tissue allografts used for surgical procedure are cartilage allografts, tendon allografts, meniscus, ligament allografts, artificial cornea, dental allografts, collagen allografts, and amniotic allografts. The global soft tissue market is driven by better quality alternatives to autografts and technological advancements.
Increase in clinical application in medical procedures & sports injuries and rise in prevalence of degenerative joint diseases are projected to drive the global soft tissue market. Clinical application of soft tissue in medical procedures and sports injuries is gradually increasing across the globe. Diabetic foot ulcer is a leading cause for hospitalization and is associated with significant morbidity and mortality. According to a report by the Transplant Department of Cleveland Clinic, nearly 30,000 surgeries with allograft tissue are performed every year in Cleveland Clinic, including meniscal transplants and anterior cruciate ligament procedures.
Rise in prevalence of degenerative joint diseases is projected to drive the demand for soft tissue products. According to World Health Organization statistics, degenerative joint diseases affect 9.6% men and 18% women aged over 60 having symptomatic osteoarthritis.
Report Scope of the Soft Tissue Market
|Market Size||US$ 8.5 Billion by 2030|
|Growth Rate||CAGR of 7.1% From 2021 to 2030|
|Forecast Period||2021 to 2030|
|Largest Market||North America|
|Fastest Growing Market||Asia Pacific|
|Companies Mentioned||Corneat Vision, LinkoCare Life Sciences AB, Presbia plc, Bone Bank Allografts, MTF Biologics, CONMED Corporation, AlloSource, Arthrex, Inc., Zimmer Biomet Holdings, Inc., and RTI Surgical, Inc|
Better Quality Alternative to Autografts, Technological Advancements to Drive Global Market
Increase in usage of allograft and better alternative to autografts are anticipated to boost the growth of the global soft tissue market. Allograft efficacy in improving stability and function comparable to reconstruction with autologous tissue makes these better alternative to autografts. Soft tissue allografts are more biocompatible than synthetic products, reducing the rates of graft rejection. In an allograft procedure, donor site morbidity is avoided. Additionally, the procedure has benefits such as reduced hospital stay & cost and availability of a range of better quality alternatives to autografts with desired size and shape. Technological advancement is a major factor driving the demand for soft tissue products. Grafts made using dCELL technology give a patient a receptive scaffold that supports cell migration during the natural healing process, while maintaining appropriate tissue strength. PASCO2 technology, developed by Alamo Tissue Service, uses supercritical carbon-dioxide to extract unwanted compounds from soft tissue allografts.
Digital Technologies Augmenting Adoption of Custom 3D Bone Allografts
The custom 3D bone allograft block fabrication is a fast growing phenomenon in the market, as the digital technology has drastically improved all areas of modern medicine and will continue to do so in the upcoming decade. Growing demand for accurate treatment planning, decline in patient chair-side time, and greater surgical accuracy have fueled the demand for custom 3D bone allografts in the modern implant dentistry. Companies in the soft tissue market are taking advantage of such developments to gain a strong research base in platelet-rich fibrin (PRF), which is being favored in regenerative dentistry.
Bone & BTB Tendon Allografts Help Deliver Ligament Reconstructions
Tendon allografts hold promising potentials in ligament reconstruction procedures. Companies in the soft tissue market are increasing their production capacities in tendon allografts, since they simplify the surgical technique by negating the need to harvest autograft, whilst eliminating issues associated with donor site morbidity. Allograft tissue specialists, Hospital Innovations, are building their product portfolio in bone & BTB (bone–patellar tendon–bone) tendon allografts that help to accommodate multiple techniques and fixation options in primary & revision ligament reconstructions.
Manufacturers in the soft tissue market are also innovating in non-bone tendon allografts that are an excellent alternative to autograft for any ligament reconstruction procedure. High quality non-bone tendon allografts have the ability to accurately size match and allows the surgeon with flexibility to perform a variety of surgical techniques.
Regenerative Biomimetic Grafts Useful for Osteochondral Lesions in Outpatient Settings
Osteochondral lesions are a tear or a fracture that involve damage to both the cartilage and underlying bone. Locate Bio – an orthobiologics-focused regenerative medicine company, has received the Breakthrough Device Designation from the U.S. FDA (Food and Drug Administration) for its biomimetic graft Chondro3 meant for osteochondral lesions.
The increasing number of knee arthroscopies performed in the U.S. each year involves a chondral lesion, which is translating into revenue opportunities for manufacturers in the global soft tissue market. Regenerative biomimetic grafts are being designed to address this growing unmet clinical need. Proprietary designs involving three-layered collagen-based biodegradable matrix that can be delivered in a single procedure are being preferred by clinicians. Manufacturers are increasing the availability of affordable biomimetic grafts that can be useful in outpatient settings.
In terms of product type, the global soft tissue market has been classified into cartilage allografts, tendon allografts, meniscus, ligament allografts, artificial cornea, dental allografts, collagen allografts, and amniotic allografts. The tendon allografts segment has been split into Achilles tendon, patellar tendon, and others. The ligament allografts segment has been bifurcated into anterior cruciate ligament and medial collateral ligament. The collagen allografts segment dominated the global soft tissue market in 2020 and the trend is expected to continue during the forecast period.
The rise in the number of musculoskeletal reconstructive procedures such as anterior cruciate ligament reconstruction is likely to increase the usage of collagen allografts. Moreover, usage of collagen allografts in maxillofacial surgery and wound care therapies is projected to drive the segment during the forecast period. Dental allografts was the second largest segment in terms of market share in 2020. Increase in regional import of surgical and dental allografts, allograft substitutes, and other acellular dermal matrix is likely to boost the segment.
In terms of end user, the global soft tissue market has been divided into hospitals, orthopedic clinics, and others. The hospitals segment led the global soft tissue market in terms of revenue in 2020 and the trend is projected to continue during the forecast period. Hospitalization for orthopedic surgeries and diabetic foot ulcers is anticipated to propel the hospitals segment. Moreover, increase in usage of soft tissue allografts for the treatment of burns and wound management contributes to the segment’s large market share. The segment is also driven by surge in number of surgeries and hospital facilities across the world.
In terms of region, the global soft tissue market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global soft tissue market in 2020, followed by Europe. North America’s large market share can be ascribed to technologically advanced research and treatment platforms, rise in anterior cruciate ligament injuries, new product launches, and presence of major players. The soft tissue market in Asia Pacific is anticipated to expand at a high CAGR from 2021 to 2031. This can be ascribed to developing countries being commercial hubs, expanding business organizations, rising awareness about soft tissue allografts, improving healthcare infrastructure, and increasing investments by companies.
Asia Pacific is anticipated to gain market share during the forecast period. Product launches, acquisitions, distribution agreements, alliances, and geographical expansion by local players, especially in China and India, are expected to propel the soft tissue market in the region.
The global soft tissue market is fragmented due to the presence of a large number of players. Key players operating in the global market include Corneat Vision, LinkoCare Life Sciences AB, Presbia plc, Bone Bank Allografts, MTF Biologics, CONMED Corporation, AlloSource, Arthrex, Inc., Zimmer Biomet Holdings, Inc., and RTI Surgical, Inc.
Soft Tissue Market, by Product
- Cartilage Allografts
- Tendon Allografts
- Achilles Tendon
- Patellar Tendon
- Ligament Allografts
- Anterior Cruciate Ligament
- Medial Collateral Ligament
- Artificial Cornea
- Dental Allografts
- Collagen Allografts
- Amniotic Allografts
- Cartilage Allografts
Soft Tissue Market, by End User
- Orthopedic Clinics
Soft Tissue Market, by Region
- North America
- Rest of Europe
- Asia Pacific
- Australia & New Zealand
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa
- North America
Research Objectives and Research Approach
The comprehensive report on the global soft tissue market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global soft tissue market in terms of product type, end user, and region. Key segments under each criteria are studied at length, and the market share for each of these at the end of 2030 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global soft tissue market.
Buy This Premium Research Report, click here@ https://www.visionresearchreports.com/report/cart/38745 or call: +1 9197 992 333